nach oben

Diabetologia

Erschienen in:

01.12.2010 | Review

Healthcare costs in patients with diabetes mellitus and comorbid mental disorders—a systematic review

verfasst von: N. Hutter, A. Schnurr, H. Baumeister

Erschienen in: Diabetologia | Ausgabe 12/2010

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

We systematically reviewed the impact of comorbid mental disorders on healthcare costs in persons with diabetes.

Method

We conducted a comprehensive search for studies investigating adult persons (≥18 years old) with diabetes mellitus. All studies that allowed comparison of healthcare costs between diabetic patients with mental disorders and those without were included.

Results

We identified 4,273 potentially relevant articles from a comprehensive database search. Of these, 31 primary studies (39 publications) fulfilled inclusion criteria, of which 27 examined comorbid depression. Hospitalisation rates and hospitalisation costs, frequency and costs of outpatient visits, emergency department visits, medication costs and total healthcare costs were mainly increased with small to moderate effect sizes in patients with diabetes and comorbid mental disorders compared with diabetic patients without such problems. Frequency (standardised mean difference [SMD] = 0.35–1.26) and costs (SMD = 0.33–0.85) of mental health specialist visits were increased in the group with mental health comorbidity. Results regarding diabetes-related preventive services were inconsistent but point to a reduced utilisation rate in diabetic patients with comorbid mental disorders. Statistical heterogeneity between studies was high (I ² range 64–98%). Pooled overall effects are therefore not reported. Studies included differ substantially regarding sample selection, assessment of diabetes and comorbid mental disorders, as well as in assessment of cost variables.

Conclusions/interpretation

In light of the increased healthcare costs and inadequate use of preventive services, comorbid mental disorders in patients with diabetes must become a major focus of diabetes healthcare and research.

Nur mit Berechtigung zugänglich

Lin EHB, Von Korff M, on behalf of the WHO WMH Survey Consortium (2008) Mental disorders among persons with diabetes—results from the World Mental Health Surveys. J Psychosom Res 65:571–580CrossRefPubMed

Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE (2000) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23:934–942CrossRefPubMed

Baumeister H, Balke K, Härter M (2005) Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. J Clin Epidemiol 58:1090–1100CrossRefPubMed

Ciechanowski PS, Katon WJ, Russo JE (2000) Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 160:3278–3285CrossRefPubMed

Gonzalez JS, Safren SA, Cagliero E et al (2007) Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care 30:2222–2227CrossRefPubMed

Das-Munshi J, Stewart R, Ismail K, Bebbington PE, Jenkins R, Prince MJ (2007) Diabetes, common mental disorders, and disability: findings from the UK National Psychiatric Morbidity Survey. Psychosom Med 69:543–550CrossRefPubMed

Hutter N, Scheidt-Nave C, Baumeister H (2009) Quality of life and health care utilization in individuals with diabetes mellitus and comorbid mental disorders. Gen Hosp Psychiatry 31:33–35CrossRefPubMed

Simon GE, Katon WJ, Lin EH et al (2005) Diabetes complications and depression as predictors of health service costs. Gen Hosp Psychiatry 27:344–351CrossRefPubMed

Jones LE, Clarke W, Carney CP (2004) Receipt of diabetes services by insured adults with and without claims for mental disorders. Med Care 42:1167–1175CrossRefPubMed

10.

Wells G, Shea B, O’Connell D et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. Available from www.ohri.ca/programs/clinical_epidemiology/oxford.htm, accessed 24 July 2007

11.

Chinn S (2000) A simple method for converting an odds ratio to effect size for use in meta-analysis. Stat Med 19:3127–3131CrossRefPubMed

12.

Greenland S, Schlesselman JJ, Criqui MH (1986) The fallacy of employing standardized regression coefficients and correlations as measures of effect. Am J Epidemiol 123:203–208PubMed

13.

Higgins JP, Green S (eds) (2009) Cochrane handbook for systematic reviews of interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration. Available from www.cochrane-handbook.org

14.

Banerjea R, Sambamoorthi U, Smelson D, Pogach LM (2008) Expenditures in mental illness and substance use disorders among veteran clinic users with diabetes. J Behav Health Serv Res 35:290–303CrossRefPubMed

15.

Black SA (1999) Increased health burden associated with comorbid depression in older diabetic Mexican Americans. Results from the Hispanic Established Population for the Epidemiologic Study of the Elderly survey. Diabetes Care 22:56–64CrossRefPubMed

16.

Chou KL, Ho AH, Chi I (2005) The effect of depression on use of emergency department services in Hong Kong Chinese older adults with diabetes. Int J Geriatr Psychiatry 20:900–902CrossRefPubMed

17.

Ciechanowski P, Russo J, Katon W et al (2006) Where is the patient? The association of psychosocial factors and missed primary care appointments in patients with diabetes. Gen Hosp Psychiatry 28:9–17CrossRefPubMed

18.

Cradock-O'Leary J, Young AS, Yano EM, Wang M, Lee ML (2002) Use of general medical services by VA patients with psychiatric disorders. Psychiatr Serv 53:874–878CrossRefPubMed

19.

Desai MM, Rosenheck RA, Druss BG, Perlin JB (2002) Mental disorders and quality of diabetes care in the veterans health administration. Am J Psychiatry 159:1584–1590CrossRefPubMed

20.

Egede LE, Zheng D, Simpson K (2002) Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 25:464–470CrossRefPubMed

21.

Egede LE, Zheng D (2003) Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes Care 26:104–111CrossRefPubMed

22.

Egede LE (2004) Effects of depression on work loss and disability bed days in individuals with diabetes. Diabetes Care 27:1751–1753CrossRefPubMed

23.

Egede LE, Ellis C, Grubaugh A (2009) The effect of depression on self-care behaviors and quality of care in a national sample of adults with diabetes. Gen Hosp Psychiatry 31:422–427CrossRefPubMed

24.

Fenton JJ, Von Korff M, Lin EH, Ciechanowski P, Young BA (2006) Quality of preventive care for diabetes: effects of visit frequency and competing demands. Ann Fam Med 4:32–39CrossRefPubMed

25.

Finkelstein EA, Bray JW, Chen H et al (2003) Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care 26:415–420CrossRefPubMed

26.

Fortney JC, Booth BM, Curran GM (1999) Do patients with alcohol dependence use more services? A comparative analysis with other chronic disorders. Alcohol Clin Exp Res 23:127–133PubMed

27.

Garis RI, Farmer KC (2002) Examining costs of chronic conditions in a Medicaid population. Manag Care 11:43–50PubMed

28.

Gilmer TP, O'Connor PJ, Rush WA et al (2005) Predictors of health care costs in adults with diabetes. Diabetes Care 28:59–64CrossRefPubMed

29.

Himelhoch S, Weller WE, Wu AW, Anderson GF, Cooper LA (2004) Chronic medical illness, depression, and use of acute medical services among Medicare beneficiaries. Med Care 42:512–521CrossRefPubMed

30.

Husaini BA, Hull PC, Sherkat DE et al (2004) Diabetes, depression, and healthcare utilization among African Americans in primary care. J Natl Med Assoc 96:476–484PubMed

31.

Kalsekar ID, Madhavan SM, Amonkar MM, Scott V, Douglas SM, Makela E (2006) The effect of depression on health care utilization and costs in patients with type 2 diabetes. Manag Care Interface 19:39–46PubMed

32.

Kalsekar ID, Madhavan SM, Amonkar MM et al (2006) Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: a retrospective cohort analysis. Clin Ther 28:306–318CrossRefPubMed

33.

Kivimäki M, Vahtera J, Pentti J, Virtanen M, Elovainio M, Hemingway H (2007) Increased sickness absence in diabetic employees: what is the role of co-morbid conditions? Diabet Med 24:1043–1048CrossRefPubMed

34.

Le TK, Able SL, Lage MJ (2006) Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression. Cost Eff Res Alloc 4:18CrossRef

35.

Lin E, Katon W, Von Korff M et al (2004) Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 27:2154–2160CrossRefPubMed

36.

Ludman E, Katon W, Russo J et al (2006) Panic episodes among patients with diabetes. Gen Hosp Psychiatry 28:475–481CrossRefPubMed

37.

Nichols L, Barton PL, Glazner J, McCollum M (2007) Diabetes, minor depression and health care utilization and expenditures: a retrospective database study. Cost Eff Resour Alloc 5:4CrossRefPubMed

38.

Niefeld MR, Braunstein JB, Wu AW, Saudek CD, Weller WE, Anderson GF (2003) Preventable hospitalization among elderly Medicare beneficiaries with type 2 diabetes. Diabetes Care 26:1344–1349CrossRefPubMed

39.

Pawaskar MD, Anderson RT, Balkrishnan R (2007) Self-reported predictors of depressive symptomatology in an elderly population with type 2 diabetes mellitus: a prospective cohort study. Health Qual Life Outcomes 5:50CrossRefPubMed

40.

Rosenzweig JL, Weinger K, Poirier-Solomon L, Rushton M (2002) Use of a disease severity index for evaluation of healthcare costs and management of comorbidities of patients with diabetes mellitus. Am J Manag Care 8:950–958PubMed

41.

Stein MB, Cox BJ, Afifi TO, Belik SL, Sareen J (2006) Does co-morbid depressive illness magnify the impact of chronic physical illness? A population-based perspective. Psychol Med 36:587–596CrossRefPubMed

42.

Subramaniam M, Sum CF, Pek E et al (2009) Comorbid depression and increased health care utilisation in individuals with diabetes. Gen Hosp Psychiatry 31:220–224CrossRefPubMed

43.

Sullivan G, Han X, Moore S, Kotrla K (2006) Disparities in hospitalization for diabetes among persons with and without co-occurring mental disorders. Psychiatr Serv 57:1126–1131CrossRefPubMed

44.

Sundaram M, Kavookjian J, Patrick JH, Miller LA, Madhavan SS, Scott VG (2007) Quality of life, health status and clinical outcomes in type 2 diabetes patients. Qual Life Res 16:165–177CrossRefPubMed

45.

Trief PM, Ouimette P, Wade M, Shanahan P, Weinstock RS (2006) Post-traumatic stress disorder and diabetes: co-morbidity and outcomes in a male veterans sample. J Behav Med 29:411–418CrossRefPubMed

46.

Vamos EP, Mucsi I, Keszei A, Kopp MS, Novak M (2009) Comorbid depression is associated with increased healthcare utilization and lost productivity in persons with diabetes: a large nationally representative Hungarian population survey. Psychosom Med 71:501–507PubMed

47.

Von Korff M, Katon W, Lin EH et al (2005) Work disability among individuals with diabetes. Diabetes Care 28:1326–1332CrossRef

48.

Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053CrossRefPubMed

49.

American Diabetes Association (2008) Economic costs of diabetes in the U.S. in 2007. Diabetes Care 31:596–615

50.

de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63:619–630PubMed

51.

Katon W, Lin EH, Kroenke K (2007) The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 29:147–155CrossRefPubMed

52.

Härter M, Baumeister H, Reuter K et al (2007) Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychother Psychosom 76:354–360CrossRefPubMed

53.

Baumeister H, Härter M (2007) Mental disorders in patients with obesity in comparison with healthy probands. Int J Obes 31:1155–1164CrossRef

54.

Kessler RC, Demler O, Frank RG et al (2005) Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 352:2515–2523CrossRefPubMed

55.

Brugha TS, Bebbington PE, Singleton N et al (2004) Trends in service use and treatment for mental disorders in adults throughout Great Britain. Br J Psychiatry 185:378–384CrossRefPubMed

56.

Baumeister H, Härter M (2007) Prevalence of mental disorders based on general population surveys. Soc Psychiatry Psychiatr Epidemiol 42:537–546CrossRefPubMed

57.

Newcomer JW, Hennekens CH (2007) Severe mental illness and risk of cardiovascular disease. JAMA 298:1794–1796CrossRefPubMed

58.

Goldman N, Lin IF, Weinstein M, Lin YH (2003) Evaluating the quality of self-reports of hyptertension and diabetes. J Clin Epidemiol 56:148–154CrossRefPubMed

59.

Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ (2004) Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 57:1096–1103CrossRefPubMed

60.

Baumeister H, Kriston L, Bengel J, Härter M (2010) High agreement of self-report and physician-diagnosed somatic conditions yields limited bias in examining mental-physical comorbidity. J Clin Epidemiol 63:558–565CrossRefPubMed

61.

Ritter PL, Stewart AL, Kaymaz H, Sobel DS, Block DA, Lorig KR (2001) Self-reports of health care utilization compared to provider records. J Clin Epidemiol 54:136–141CrossRefPubMed

62.

Lubeck DP, Hubert HB (2005) Self-report was a viable method for obtaining health care utilization data in community-dwelling seniors. J Clin Epidemiol 58:286–290CrossRefPubMed

Titel: Healthcare costs in patients with diabetes mellitus and comorbid mental disorders—a systematic review
verfasst von: N. Hutter
A. Schnurr
H. Baumeister
Publikationsdatum: 01.12.2010
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 12/2010
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-010-1873-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Method

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2010

Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age

Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass

Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin-like growth factor-I receptor

Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment

Leisure-time physical activity and type 2 diabetes during a 28 year follow-up in twins